Variations of human papillomavirus type 58 E6, E7, L1 genes and long control region in strains from women with cervical lesions in Liaoning province, China

Infection, Genetics and Evolution

Volumn 12, Issue 7, 2012, Pages 1466-1472

  Liu, Jian Hua ^a   Lu, Zhi Tao ^a   Wang, Gui Li ^a   Zhou, Wei Qiang ^a   Liu, Chao ^a   Yang, Lian Xia ^a   Sun, Zheng Rong ^a   Ruan, Qiang ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

E6, E7, L1 genes and LCR; Genetic diversity; HPV 58

Indexed keywords

ADULT; AMINO ACID SUBSTITUTION; AMPLICON; ARTICLE; ATYPICAL SQUAMOUS CELL OF UNDETERMINED SIGNIFICANCE; CHINA; CHINESE; CHIP HYBRIDIZATION ASSAY; CONTROLLED STUDY; DIRECT NUCLEOTIDE SEQUENCE; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC IDENTIFICATION; GENETIC VARIABILITY; HPV 58 GENE; HPV E6 GENE; HPV E7 GENE; HPV L1 GENE; HUMAN; HUMAN CELL; HYBRIDIZATION; LONG CONTROL REGION; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; SAMPLE; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVICITIS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DISEASE; VIRUS GENE; VIRUS STRAIN;

ADULT; AGED; ALPHAPAPILLOMAVIRUS; CAPSID PROTEINS; CHINA; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; PREVALENCE; RESPONSE ELEMENTS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84865370957     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2012.05.004     Document Type: Article

References (41)

1. Bae J.H., Cheung J.L., Lee S.J., Luk A.C., Tong S.Y., Chan P.K., Park J.S. Distribution of human papillomavirus type 58 variants in progression of cervical dysplasia in Korean women. J. Microbiol. Biotechnol. 2009, 19:1051-1054.
2. Bishop B., Dasgupta J., Klein M., Garcea R.L., Christensen N.D., Zhao R., Chen X.S. Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies. J. Biol. Chem. 2007, 282:31803-31811.
3. Calleja-Macias I.E., Villa L.L., Prado J.C., Kalantari M., Allan B., Williamson A.L., Chung L.P., Collins R.J., Zuna R.E., Dunn S.T., Chu T.Y., Cubie H.A., Cuschieri K., von Knebel-Doeberitz M., Martins C.R., Sanchez G.I., Bosch F.X., Munoz N., Bernard H.U. Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. J. Virol. 2005, 79:13630-13640.
4. Cento V., Ciccozzi M., Ronga L., Perno C.F., Ciotti M. Genetic diversity of human papillomavirus type 16 E6, E7, and L1 genes in Italian women with different grades of cervical lesions. J. Med. Virol. 2009, 81:1627-1634.
5. Cento V., Rahmatalla N., Ciccozzi M., Perno C.F., Ciotti M. Intratype variations of HPV 31 and 58 in Italian women with abnormal cervical cytology. J. Med. Virol. 2011, 83:1752-1761.
6. Chan P.K., Lam C.W., Cheung T.H., Li W.W., Lo K.W., Chan M.Y., Cheung J.L., Cheng A.F. Association of human papillomavirus type 58 variant with the risk of cervical cancer. J. Natl. Cancer I. 2002, 94:1249-1253.
7. Chan P.K., Luk A.C., Park J.S., Smith-McCune K.K., Palefsky J.M., Konno R., Giovannelli L., Coutlee F., Hibbitts S., Chu T.Y., Settheetham-Ishida W., Picconi M.A., Ferrera A., De Marco F., Woo Y.L., Raiol T., Pina-Sanchez P., Cheung J.L., Bae J.H., Chirenje M.Z., Magure T., Moscicki A.B., Fiander A.N., Di Stefano R., Cheung T.H., Yu M.M., Tsui S.K., Pim D., Banks L. Identification of human papillomavirus type 58 lineages and the distribution worldwide. J. Infect. Dis. 2011, 203:1565-1573.
8. Chang Y.J., Chen H.C., Lee B.H., You S.L., Lin C.Y., Pan M.H., Chou Y.C., Hsieh C.Y., Chen Y.M., Cheng Y.J., Chen C.J. Unique variants of human papillomavirus genotypes 52 and 58 and risk of cervical neoplasia. Int. J. Cancer 2011, 129:965-973.
9. Chen X.S., Garcea R.L., Goldberg I., Casini G., Harrison S.C. Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol. Cell 2000, 5:557-567.
10. Clifford G.M., Rana R.K., Franceschi S., Smith J.S., Gough G., Pimenta J.M. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidem. Biomar. 2005, 14:1157-1164.
11. Clifford G.M., Smith J.S., Aguado T., Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Brit. J. Cancer 2003, 89:101-105.
12. Clifford G.M., Smith J.S., Plummer M., Munoz N., Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Brit. J. Cancer 2003, 88:63-73.
13. Cogliano V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F. Carcinogenicity of human papillomaviruses. Lancet Oncol. 2005, 6:204.
14. De Boer M.A., Peters L.A., Aziz M.F., Siregar B., Cornain S., Vrede M.A., Jordanova E.S., Fleuren G.J. Human papillomavirus type 18 variants: histopathology and E6/E7 polymorphisms in three countries. Int. J. Cancer 2005, 114:422-425.
15. Ding T., Wang X., Ye F., Cheng X., Ma D., Lu W., Xie X. Distribution of human papillomavirus 58 and 52 E6/E7 variants in cervical neoplasia in Chinese women. Gynecol. Oncol. 2010, 119:436-443.
16. Giannoudis A., Herrington C.S. Human papillomavirus variants and squamous neoplasia of the cervix. J. Pathol. 2001, 193:295-302.
17. Herrero R., Castellsague X., Pawlita M., Lissowska J., Kee F., Balaram P., Rajkumar T., Sridhar H., Rose B., Pintos J., Fernandez L., Idris A., Sanchez M.J., Nieto A., Talamini R., Tavani A., Bosch F.X., Reidel U., Snijders P.J., Meijer C.J., Viscidi R., Munoz N., Franceschi S. Human papillomavirus and oral cancer: the international agency for research on cancer multicenter study. J. Natl. Cancer Inst. 2003, 95:1772-1783.
18. Hildesheim A., Schiffman M., Bromley C., Wacholder S., Herrero R., Rodriguez A., Bratti M.C., Sherman M.E., Scarpidis U., Lin Q.Q., Terai M., Bromley R.L., Buetow K., Apple R.J., Burk R.D. Human papillomavirus type 16 variants and risk of cervical cancer. J. Natl. Cancer Inst. 2001, 93:315-318.
19. Hubert W.G. Variant upstream regulatory region sequences differentially regulate human papillomavirus type 16 DNA replication throughout the viral life cycle. J. Virol. 2005, 79:5914-5922.
20. IARC, 2007. Human papillomaviruses. IARC Monogr. Eval. Carcinog. Risks Hum. 90, 1-636.
21. Jiang M., Milner J. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 2002, 21:6041-6048.
22. Kammer C., Tommasino M., Syrjanen S., Delius H., Hebling U., Warthorst U., Pfister H., Zehbe I. Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease. Brit. J. Cancer 2002, 86:269-273.
23. Kirii Y., Iwamoto S., Matsukura T. Human papillomavirus type 58 DNA sequence. Virology 1991, 185:424-427.
24. Lowy D.R., Schiller J.T. Prophylactic human papillomavirus vaccines. J. Clin. Invest. 2006, 116:1167-1173.
25. Minosse C., Garbuglia A.R., Lapa D., Sias C., Zaniratti M.S., Capobianchi M.R. Genetic variability in E6, E7 and L1 protein of HPV81 from HIV-1 positive women in Italy. New Microbiol. 2010, 33:25-35.
26. Munger K., Baldwin A., Edwards K.M., Hayakawa H., Nguyen C.L., Owens M., Grace M., Huh K. Mechanisms of human papillomavirus-induced oncogenesis. J. Virol. 2004, 78:11451-11460.
27. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., Snijders P.J., Meijer C.J. Epidemiologic classification of human papillomavirus types associated with cervical cancer. New Engl. J. Med. 2003, 348:518-527.
28. Ntova C.K., Kottaridi C., Chranioti A., Spathis A., Kassanos D., Paraskevaidis E., Karakitsos P. Genetic variability and phylogeny of high risk HPV type 16, 18, 31, 33 and 45 L1 gene in Greek women. Int. J. Mol. Sci. 2012, 13:1-17.
29. Pande S., Jain N., Prusty B.K., Bhambhani S., Gupta S., Sharma R., Batra S., Das B.C. Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India. J. Clin. Microbiol. 2008, 46:1060-1066.
30. Pastrana D.V., Vass W.C., Lowy D.R., Schiller J.T. NHPV16 VLP vaccine induces human antibodies that neutralize divergent variants of HPV16. Virology 2001, 279:361-369.
31. Raiol T., Wyant P.S., de Amorim R.M., Cerqueira D.M., Milanezi N.G., Brigido Mde M., Sichero L., Martins C.R. Genetic variability and phylogeny of the high-risk HPV-31, -33, -35, -52, and -58 in central Brazil. J. Med. Virol. 2009, 81:685-692.
32. Smith J.S., Lindsay L., Hoots B., Keys J., Franceschi S., Winer R., Clifford G.M. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int. J. Cancer 2007, 121:621-632.
33. Stephen A.L., Thompson C.H., Tattersall M.H., Cossart Y.E., Rose B.R. Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from central China. Int. J. Cancer 2000, 86:695-701.
34. Sun Z.R., Zhou J.Y., Zhang W.Q., Jiang S.L., Ruan Q W.G. Characteristic of HPV prevalence among women in Liaoning province, China. Int. J. Gynecol. Obstet. 2010, 109(2):105-109.
35. Tornesello M.L., Duraturo M.L., Buonaguro L., Vallefuoco G., Piccoli R., Palmieri S., Buonaguro F.M. Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy. Infect. Agent Cancer 2007, 2:1-9.
36. Wu E.Q., Zha X., Yu X.H., Zhang G.N., Wu Y.G., Fan Y., Ren Y., Kong L.Q., Kong W. Profile of physical status and gene variation of human papillomavirus 58 genome in cervical cancer. J. Gen. Virol. 2009, 90:1229-1237.
37. Xin C.Y., Matsumoto K., Yoshikawa H., Yasugi T., Onda T., Nakagawa S., Yamada M., Nozawa S., Sekiya S., Hirai Y., Shiromizu K., Fujii T., Taketani Y. Analysis of E6 variants of human papillomavirus type 33, 52 and 58 in Japanese women with cervical intraepithelial neoplasia/cervical cancer in relation to their oncogenic potential. Cancer Lett. 2001, 170:19-24.
38. Yang R., Wheeler C.M., Chen X., Uematsu S., Takeda K., Akira S., Pastrana D.V., Viscidi R.P., Roden R.B. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer. J. Virol. 2005, 79:6741-6750.
39. Zehbe I., Voglino G., Delius H., Wilander E., Tommasino M. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet 1998, 352:1441-1442.
40. Zehbe I., Wilander E., Delius H., Tommasino M. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res. 1998, 58:829-833.
41. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2002, 2:342-350.